surpass 5 tirzepatide reduces albuminuria among adults with type 2 diabetes in trials TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO

doi: 10.3389/fbioe.2026.1797044 Received 27 January 2026 Revised 28 February 2026 Accepted 12 March 2026 Published 01 April 2026 Volume 14 - 2026 Edited by Matteo Battaglini, Italian Institute of Technology (IIT), Italy Reviewed by Patrizia Guidi, University of Pisa, Italy Yuhong Nie, Sichuan No

Not because they're negligent

Looking ahead, Mounjaro expected to receive FDA approval for weight loss by mid-2024

Revolutionizing diabetes care: Unveiling tirzepatides potential in glycemic control and beyond

The importance of weight management in type 2 diabetes mellitus

When misfolded proteins are not adequately removed from cells, protein aggregation may occur, and these are hallmarks of some neurodegenerative diseases including Alzheimers (beta amyloid plaques) and Parkinsons (alpha synuclein-containing Lewy bodies)